netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Raloxifene found 11 matches
Open monograph to display formulary status BNF Category
  Raloxifene Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
  Raloxifene Hydrochloride Endocrine system - Raloxifene - 06.04.01.01
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA160: Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.01)
link in drug section NICE TA160: Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.01)
link in subsection NICE TA160: Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.02)
link in drug section NICE TA160: Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (Not Approved) (06.04.01.01)
link in drug section NICE TA161: Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (06.04.01.01)
link in drug section NICE TA161: Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.01)
link in subsection NICE TA161: Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.02)
link in drug section NICE TA161: Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (06.06.01)

SubSection Titles / notes  
Raloxifene - (06.04.01.01)

 
netFormulary